NASDAQ
Ligand Pharmaceuticals Incorporated (LGND) has a eps (basic) of $6.44 as of Wednesday, December 31, 2025. Basic EPS divides net income by the weighted average number of common shares outstanding, measuring profit allocated to each share.
No price data available for this timeframe.